Invitae Corporation
NVTA
Rangering i aksjer
#35777
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Aksjekurs
$0.016
Sist synkronisert: 2024-03-11
Markedsverdi
$3.27M
Endring (1 dag)
-5.33%
Endring (1 år)
5,233.33%
Land
US
Handel Invitae Corporation (NVTA)
Kategori
Healthcare
Antall utestående aksjer for Invitae Corporation (NVTA)
Antall utestående aksjer per September 2023: 275.60M
Ifølge Invitae Corporation sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 275.60M. Ved slutten av December 2022 hadde selskapet 235.68M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Invitae Corporation (NVTA) fra 2016 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 275.60M | 0.00% |
| 2023 | 275.60M | 16.94% |
| 2022 | 235.68M | 11.72% |
| 2021 | 210.95M | 56.74% |
| 2020 | 134.59M | 48.13% |
| 2019 | 90.86M | 36.12% |
| 2018 | 66.75M | 43.51% |
| 2017 | 46.51M | 40.20% |
| 2016 | 33.18M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 371.00M | 34.61% |
US
|
|
| 705.30M | 155.91% |
US
|
|
| 143.28M | -48.01% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 2.32% |
US
|
